AZN
David Fredrickson
Analyst
Oncology and Hematology Business Leader
Analyst
Oncology Chief
Analyst
Oncology
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Fredrickson
David Fredrickson is recorded as Analyst at Oncology and Hematology Business Leader, Analyst at Oncology Chief and Analyst at Oncology.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Oncology and Hematology Business Leader
Analyst
Source not stated
Current -
Oncology Chief
Analyst
Source not stated
Current -
Astrazeneca PLC (AZN)
Source not stated
Current -
Oncology
Analyst
Source not stated
Current -
Caris Life Sciences, Inc. (CAI)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Caris Life Sciences, Inc.
Other people whose current roles at this company are on record from its filings.
- David Dean Halbert CEO
- Jeffrey Vacirca CEO
- Brian J. Brille Chairman
- Jon S. Halbert Chairman
- Peter M. Castleman Chairman
- Danny Phillips CFO
- Joseph E. Gilliam COO
- J. Russel Denton General Counsel
- Laura I. Johansen General Counsel
Recent activity
No call appearances or filed executive changes recorded yet.